
IMC Congratulates C.D. Howe Institute on Timely Report Supporting Practical Pharmacare Solutions
Report is an Evidence-Based Contribution to One of Canada’s Most Important and Complex Health Policy Challenges Ottawa, Sept. 19, 2025 […]
Put your finger on the pulse of the healthcare industry.
For media inquiries, please contact us at media@imc-mnc.ca.
Report is an Evidence-Based Contribution to One of Canada’s Most Important and Complex Health Policy Challenges Ottawa, Sept. 19, 2025 […]
National Advocacy Platform will Champion Patient Access and Health Innovation Ottawa, September 16 – Innovative Medicines Canada (IMC) is proud […]
Geneva and Ottawa, June 12 – Ahead of the upcoming G7 Leaders’ Summit, the global pharmaceutical industry, represented by the […]
Dear G7 Governments, On behalf of the innovative pharmaceutical industry we represent, we would like to convey ahead of the […]
Ottawa, May 27, 2025 – Today, His Majesty King Charles III delivered the Speech from the Throne, outlining the federal […]
Ottawa, May 26, 2025 – Innovative Medicines Canada welcomes the launch of CanReview, a pan-Canadian initiative supported by the Accelerating […]
Report is an Evidence-Based Contribution to One of Canada’s Most Important and Complex Health Policy Challenges Ottawa, Sept. 19, 2025 […]
As originally published in BIOTEC Insights magazine here, June 17, 2025. Authored by: Dr. Bettina Hamelin President, Innovative Medicines Canada FOR THE […]
Geneva and Ottawa, June 12 – Ahead of the upcoming G7 Leaders’ Summit, the global pharmaceutical industry, represented by the […]
Get in touch Please complete the form below, and a representative will be in touch as soon as possible. Departments […]
At Innovative Medicines Canada, we offer sponsorship opportunities to facilitate research, generate awareness, create educational programs, and improve access to innovative medicines.
Sign up to our newsletter to get our latest news and updates.
Browse by topic
Informative content to keep you up to date on the most pressing issues facing our industry.